Search Results

Medizone International, Inc. (OTCQB:MZEI) or Medizone, manufacturer of the AsepticSure® system, today announced that the Company has submitted a request to the Securities and Exchange Commission to withdraw its S-1 Registration Statement (File No. 333-222991) (the “Registration Statement”) on file with the U.S. Securities and Exchange Commission (the “SEC”)

Medizone International, Inc. (OTCQB:MZEI) or Medizone, manufacturer of the AsepticSure® system, today announced the initiation of a Product Evaluation Agreement (the “Agreement”) with Innovasource, LLC, a leading manufacturer of cleaning, deodorizing and disinfecting products (“Innovasource”).

Medizone today announced the appointment of Jude P. Dinges, as its Executive VP - Commercial Operations.

Medizone International, Inc. announced the implementation and expansion of the Product Evaluation Agreement (the “Agreement”) with Innovasource, LLC.

Medizone today announced the appointment of Philip A. Theodore, as its Executive VP-Operations and Administration, General Counsel and Corporate Secretary.

Medizone and Aglon a/s today announced that they have entered into an agreement for the introduction and distribution of AsepticSure in the Nordic Region.

Medizone Internationalor Medizone, manufacturer of the AsepticSure Disinfection System, today announced that it is now allowed to place the “CE” Mark on the AsepticSure System

Medizone today announced that it will meet with representatives of the FDA on January 18, 2018 to discuss the planned submission of a marketing application for AsepticSure.

Pursuant to the Supply Agreement, Innovasource will supply its custom-formulated, EPA-registered hydrogen peroxide based disinfectant product to Medizone for use in the AsepticSure Disinfection System.

Medizone announced today the Company’s management will be attending the J.P. Morgan 36th Annual Healthcare Conference in San Francisco, January 8th through 11th.